Magnetic nanoformulation of azidothymidine 5’-triphosphate for targeted delivery across the blood–brain barrier

Despite significant advances in highly active antiretroviral therapy (HAART), the prevalence of neuroAIDS remains high. This is mainly attributed to inability of antiretroviral therapy (ART) to cross the blood–brain barrier (BBB), thus resulting in insufficient drug concentration within the brain. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Saiyed, Zainulabedin M, Gandhi, Nimisha H, Nair, Madhavan PN
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865010/
https://www.ncbi.nlm.nih.gov/pubmed/20463931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865010/
https://www.ncbi.nlm.nih.gov/pubmed/20463931

Ejemplares similares